Cargando…
Therapeutic Options for Coronavirus Disease 2019 (COVID-19) - Modulation of Type I Interferon Response as a Promising Strategy?
Autores principales: | Mary, Aurélien, Hénaut, Lucie, Schmit, Jean-Luc, Lanoix, Jean-Philippe, Brazier, Michel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7243823/ https://www.ncbi.nlm.nih.gov/pubmed/32574289 http://dx.doi.org/10.3389/fpubh.2020.00185 |
Ejemplares similares
-
Rationale for COVID-19 Treatment by Nebulized Interferon-β-1b–Literature Review and Personal Preliminary Experience
por: Mary, Aurélien, et al.
Publicado: (2020) -
Which features of an outpatient treatment for COVID-19 would be most important for pandemic control? A modelling study
por: Lanoix, Jean-Philippe, et al.
Publicado: (2021) -
Exergaming: A Good Exercise Option During the Coronavirus Pandemic
por: Paalani, Michael, et al.
Publicado: (2023) -
The association between body mass index class and coronavirus disease 2019 outcomes
por: Al-Salameh, Abdallah, et al.
Publicado: (2020) -
Intervertebral disc degeneration—Current therapeutic options and challenges
por: Samanta, Ankita, et al.
Publicado: (2023)